Trial Profile

A Phase IIb Study Evaluating the Safety and Efficacy of Multiple Doses of CNS 7056 Compared to Midazolam in Patients Undergoing Colonoscopy

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 10 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Remimazolam (Primary) ; Midazolam
Indications Sedation
Focus Therapeutic Use
Sponsors PAION

Most Recent Events

19 Jun 2016 Results published in a PAION media release.
12 Nov 2014 New trial record
01 Oct 2014 Results published in PAION media release, and presented at the American College of Gastroenterology Annual Scientific Meeting (ACG) in October 2014, according the media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com